EMPHYSEMATOUS BULLA

This adverse event was reported 7 times

EMPHYSEMATOUS BULLA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DEXCHLORPHENIRAMINE MALEATE 1 0.0010
1 SULINDAC 1 0.0004
2 DEFLAZACORT 1 0.0004
3 PENTOSAN POLYSULFATE SODIUM 1 0.0001
4 PAROXETINE HYDROCHLORIDE 2 0.0000
5 IBUPROFEN AND DIPHENHYDRAMINE CITRATE 1 0.0000
6 THALIDOMIDE 1 0.0000
7 TEMAZEPAM 1 0.0000
8 CLONIDINE 1 0.0000
9 ENOXAPARIN SODIUM 1 0.0000
See all drugs enriched for association with EMPHYSEMATOUS BULLA

EMPHYSEMATOUS BULLA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
1 Topoisomerase Inhibitor [EPC] 1 0.0000
2 Aminosalicylate [EPC] 1 0.0000
3 Proteasome Inhibitor [EPC] 1 0.0000
4 Benzodiazepine [EPC] 3 0.0000
5 Alkylating Drug [EPC] 1 0.0000
6 Opioid Agonist [EPC] 1 0.0000
7 Platinum-based Drug [EPC] 1 0.0000
8 Corticosteroid [EPC] 3 0.0000
9 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with EMPHYSEMATOUS BULLA